Perbak Capital Partners’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$986K Buy
7,631
+4,626
+154% +$665K 0.24% 66
2025
Q4
$429K Sell
3,005
-8,241
-73% -$1.1M 0.13% 74
2025
Q3
$1.35M Buy
11,246
+6,547
+139% +$830K 0.24% 69
2025
Q2
$621K Buy
+4,699
New +$637K 0.14% 151

Other funds holding ICUI

Perbak Capital Partners's ICUI Position: Q1 2026 in Review

Perbak Capital Partners increased its ICU Medical (ICUI) stake by 154% in Q1 2026, buying an estimated $665K and bringing the position to 7,631 shares worth $986K. The position accounts for 0.24% of the portfolio, ranked #66.

Perbak Capital Partners first reported a position in ICUI in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.35M in Q3 2025. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.

  • Perbak Capital Partners held 7,631 shares of ICU Medical worth $986K as of Q1 2026.
  • Perbak Capital Partners bought 4,626 ICU Medical shares in Q1 2026, an estimated $665K.
  • ICU Medical made up 0.24% of Perbak Capital Partners's portfolio in Q1 2026, its #66 holding.
  • Perbak Capital Partners first reported a position in ICU Medical in Q2 2025 and has held it in 4 quarters since.
  • Perbak Capital Partners's ICU Medical position peaked at $1.35M in Q3 2025.
  • 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.

Based on Perbak Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.